CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

70 hedge funds and large institutions have $19.8M invested in Carisma Therapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14M
Puts
$1.09M
Net Calls
Net Calls Change

Top Buyers

1 +$282K
2 +$174K
3 +$166K
4
E
Ergoteles
New York
+$63.5K
5
CL
CSS LLC
Illinois
+$58.3K

Top Sellers

1 -$964K
2 -$110K
3 -$106K
4
Morgan Stanley
Morgan Stanley
New York
-$97.2K
5
GCP
GSA Capital Partners
United Kingdom
-$80K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$30K
27
$27K
28
$19.4K
29
$19K
30
$18.4K
31
$18.3K
32
$18.3K
33
$17.4K
34
$16.1K
35
$15K
36
$13.8K
37
$13.7K
38
$13.4K
39
$13K
40
$12.8K
41
$12.6K
42
$12.2K
43
$12K
44
$11K
45
$11K
46
$9.64K
47
$8.33K
48
$7.92K
49
$7.31K
50
$7.1K